ES2062332T3 - Benzoxazolonas antiinflamatorias. - Google Patents

Benzoxazolonas antiinflamatorias.

Info

Publication number
ES2062332T3
ES2062332T3 ES90301941T ES90301941T ES2062332T3 ES 2062332 T3 ES2062332 T3 ES 2062332T3 ES 90301941 T ES90301941 T ES 90301941T ES 90301941 T ES90301941 T ES 90301941T ES 2062332 T3 ES2062332 T3 ES 2062332T3
Authority
ES
Spain
Prior art keywords
mammal
inflammatory
benzoxazolinones
compounds
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90301941T
Other languages
English (en)
Inventor
Kazuo Taito Pfizer Apartm Ando
Nobuko Taito Pfizer Apart Asai
Fumitaka - - Sakuragaoka- Ito
Takashi Mano
Masami Nakane
Kunio Satake
Kaoru Shimada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of ES2062332T3 publication Critical patent/ES2062332T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

ESTE INVENTO SE REFIERE A CIERTAS BENZOXAZOLONAS QUE INHIBEN LAS ENZIMAS LIPOXIGENASA Y / O CICLOXIGENASA. DICHOS COMPUESTOS SON UTILES EN INHIBIR TALES ENZIMAS "PER SE", Y SON UTILES EN EL TRATAMIENTO ALERGICO Y CONDICIONES INFLAMATORIAS EN UN MAMIFERO. ESTE INVENTO TAMBIEN SE REFIERE A METODOS DE INHIBIR LA LIPOXIGENASA Y / O LA CICLOXIGENASA EN UN MAMIFERO CON DICHAS BENZOXAZOLONAS; A METODOS EN TRATAMIENTO EN CONDICIONES ALERGICAS EN UN MAMIFERO CON TALES COMPUESTOS; A METODOS DE TRATAMIENTO EN CONDICIONES ANTINFLAMATORIAS EN UN MAMIFERO CON DICHOS COMPUESTOS; A LOS COMPUESTOS FARMACEUTICOS QUE COMPRENDEN LAS BENZOXAZOLONAS DEL INVENTO.
ES90301941T 1989-02-28 1990-02-23 Benzoxazolonas antiinflamatorias. Expired - Lifetime ES2062332T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4742989 1989-02-28

Publications (1)

Publication Number Publication Date
ES2062332T3 true ES2062332T3 (es) 1994-12-16

Family

ID=12774907

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90301941T Expired - Lifetime ES2062332T3 (es) 1989-02-28 1990-02-23 Benzoxazolonas antiinflamatorias.

Country Status (24)

Country Link
US (1) US5086062A (es)
EP (1) EP0385664B1 (es)
JP (1) JPH0730053B2 (es)
KR (1) KR920010641B1 (es)
CN (1) CN1045264A (es)
AT (1) ATE100091T1 (es)
AU (1) AU617041B2 (es)
CA (1) CA2010765A1 (es)
DD (1) DD292256A5 (es)
DE (1) DE69005852T2 (es)
DK (1) DK0385664T3 (es)
ES (1) ES2062332T3 (es)
FI (1) FI900979A0 (es)
HU (1) HUT58328A (es)
IE (1) IE900695L (es)
IL (1) IL93473A0 (es)
MY (1) MY105263A (es)
NO (1) NO900915L (es)
NZ (1) NZ232707A (es)
PL (2) PL163378B1 (es)
PT (1) PT93257A (es)
RU (2) RU2036913C1 (es)
YU (1) YU37490A (es)
ZA (1) ZA901480B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0678327B2 (ja) * 1989-07-20 1994-10-05 ファイザー製薬株式会社 ４，５，６，７，―四置換ベンゾオキサゾロン類
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
DE10210779A1 (de) * 2002-03-12 2003-10-09 Merck Patent Gmbh Cyclische Amide
RU2477283C1 (ru) * 2012-02-27 2013-03-10 Федеральное государственное бюджетное учреждение науки Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН) 4,7-ДИМЕТИЛ-2-(2,4,5-ТРИМЕТОКСИФЕНИЛ)-3,4,4a,5,8,8a-ГЕКСАГИДРО-2H-4,8-ЭПОКСИХРОМЕН, ОБЛАДАЮЩИЙ АНАЛЬГЕЗИРУЮЩЕЙ АКТИВНОСТЬЮ

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3017977A1 (de) * 1980-05-10 1981-11-19 Dr. Karl Thomae Gmbh, 7950 Biberach Neue substituierte 2(3h)-benzothiazolone
FR2491066A1 (fr) * 1980-09-29 1982-04-02 Cerm Cent Europ Rech Mauvernay Benzoxazolinones substituees en 6 par une chaine aminoalcool ou aminocetone, leur preparation et leur application en therapeutique
GB8325370D0 (en) * 1983-09-22 1983-10-26 Fujisawa Pharmaceutical Co Benzoxazoline and benzothiazoline derivatives
DK288287A (da) * 1986-06-09 1987-12-10 Pfizer Heterocycliske forbindelser samt farmaceutiske praeparater til behandling af allergiske eller inflammatoriske tilstande
US4835166A (en) * 1986-06-09 1989-05-30 Pfizer Inc. Antiallergy and antiinflammatory agents
JPH0283376A (ja) * 1988-09-19 1990-03-23 Pfizer Pharmaceut Co Ltd ベンゾオキサゾロン誘導体および抗アレルギー又は抗炎症組成物

Also Published As

Publication number Publication date
HUT58328A (en) 1992-02-28
US5086062A (en) 1992-02-04
AU5056690A (en) 1990-09-06
IE900695L (en) 1990-08-28
AU617041B2 (en) 1991-11-14
NO900915L (no) 1990-08-29
CN1045264A (zh) 1990-09-12
NZ232707A (en) 1991-01-29
RU2036913C1 (ru) 1995-06-09
RU2024512C1 (ru) 1994-12-15
DE69005852T2 (de) 1994-04-28
DD292256A5 (de) 1991-07-25
ZA901480B (en) 1991-10-30
PT93257A (pt) 1990-08-31
YU37490A (en) 1992-05-28
CA2010765A1 (en) 1990-08-31
PL163419B1 (pl) 1994-03-31
HU901063D0 (en) 1990-05-28
NO900915D0 (no) 1990-02-27
EP0385664A2 (en) 1990-09-05
PL284026A1 (en) 1991-04-08
KR920010641B1 (ko) 1992-12-12
DE69005852D1 (de) 1994-02-24
MY105263A (en) 1994-09-30
DK0385664T3 (da) 1994-02-14
EP0385664A3 (en) 1991-03-06
JPH0730053B2 (ja) 1995-04-05
KR910015571A (ko) 1991-09-30
PL288077A1 (en) 1991-12-02
JPH03218368A (ja) 1991-09-25
PL163378B1 (pl) 1994-03-31
FI900979A0 (fi) 1990-02-27
IL93473A0 (en) 1990-11-29
EP0385664B1 (en) 1994-01-12
ATE100091T1 (de) 1994-01-15

Similar Documents

Publication Publication Date Title
ES2059296T3 (es) Inhibidores de proteasas retrovirales.
PT618190E (pt) 9-¬glicil substituido)amido|-6-(substituido)-5-hidroxi-6-desoxitetraciclinas
DE69725825D1 (de) 5-HT1F-Agonisten
IS6097A (is) Frumuviðloðunar-bælandi bólgu-eyðandi og ónæmisbælandi efnasambönd
EA199900362A1 (ru) Новые соединения, полезные для использования в качестве нейрозащитных средств
BR9106367A (pt) Acidos e n-hidroxiureias anti-inflamatorias
FI900041A0 (fi) Substituerade indol-, benzofuran- och benzotiopenderivat saosom 5-lipoxigenasinhibitorer,
ATE131154T1 (de) Phenylalkan(en)säuren.
ES2062332T3 (es) Benzoxazolonas antiinflamatorias.
FI892222A (fi) Peptidalkoholer med antikoagulantverkan.
TR22217A (tr) Bitki oeldueruecue 2,6-bis-florometil-dihidropiridin-3,5-dikarboksilik asit esterleri
NO892189L (no) Trijodbenzenforbindelser og kontrastmidler for radiografiinneholdende disse.
ATE85331T1 (de) Azolverbindungen.
ES2086395T3 (es) Fosfolipidos para el tratamiento de esclerosis multiple.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 385664

Country of ref document: ES